Enhancing Therapeutic Efficacy against <i>Brucella canis</i> Infection in a Murine Model Using Rifampicin-Loaded PLGA Nanoparticles-Reference-Cited by-同舟云学术

Enhancing Therapeutic Efficacy against Brucella canis Infection in a Murine Model Using Rifampicin-Loaded PLGA Nanoparticles

Published:2023-12-13 Issue:51 Volume:8 Page:49362-49371
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Hernández-Giottonini Karol Yesenia¹²^ORCID,Arellano-Reynoso Beatriz³,Rodríguez-Córdova Rosalva Josefina¹²,de la Vega-Olivas Jonathan²,Díaz-Aparicio Efrén⁴,Lucero-Acuña Armando¹²^ORCID

Affiliation:

1. Posgrado en Nanotecnología, Departamento de Física, Universidad de Sonora, Hermosillo 83000, Mexico

2. Departamento de Ingeniería Química y Metalurgia, Universidad de Sonora, Hermosillo 83000, Mexico

3. Facultad de Medicina Veterinaria y Zootecnia, Universidad Nacional Autónoma de México, Circuito Exterior Ciudad Universitaria, Coyoacán, Ciudad de México 04510, Mexico

4. CENID Salud Animal e Inocuidad, Instituto Nacional de Investigaciones Forestales, Agrícolas y Pecuarias, Carretera Federal México-Toluca Km. 15.5, Cuajimalpa, Ciudad de México 05110, Mexico

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.3c07892

Reference57 articles.

1. A clinical perspective of chitosan nanoparticles for infectious disease management

2. Bruselloz; Endemik Bölgelerde Tanı Zorluğu

3. Brucellosis: Improved Diagnostics and Vaccine Insights from Synthetic Glycans

4. Novel Vertical Flow Immunoassay with Au@PtNPs for Rapid, Ultrasensitive, and On-Site Diagnosis of Human Brucellosis

5. Public and animal health risks associated with spillover of Brucella melitensis into dairy farms